BOC Sciences - Products
London
BOC Sciences provides various research (bio)chemicals: inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities, metabolites, APIs, natural compounds, ADCs, and chiral compounds.
| Product | Description | |
|---|---|---|
| A 71915 | A 71915 is a highly potent and competitive natriuretic peptide receptor A (NPRA) antagonist (pKi = 9.18). Group: Pharmaceutical. CAS No. 132956-87-7. Pack Sizes: 1mg; 1g; 10g. Product ID: BAT-015128. Molecular formula: Custom synthesis is available. Send your inquiries for more information. |  London |
| A-72363 A1 | A-72363 A1 is a Heparanase inhibitor produced by Streptomyces nobilis SANK 60192. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Product ID: BBF-03163. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| A-72363 A2 | A-72363 A2 is a Heparanase inhibitor produced by Streptomyces nobilis SANK 60192. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Product ID: BBF-03164. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| A-72363 C | A-72363 C is a Heparanase inhibitor produced by Streptomyces nobilis SANK 60192. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Product ID: BBF-03165. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| A-75943 | A-75943 is is a bone resorption inhibitor produced by Streptomyces sp. SANK61296. In vitro tests, it has the effect of inhibiting bone resorption with IC50 of 0.35 μmol/L. It also inhibits the bone resorption in rats with thyroid and parathyroidectomy. Group: Pharmaceutical. CAS No. 201215-10-3. Pack Sizes: 1mg; 1g; 10g. Product ID: BBF-03166. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| A 779 | A 779 is a specific antagonist of G-protein coupled receptor (Mas receptor) (IC50 = 0.3 nM) with no significant affinity for AT1 or AT2 receptors at a concentration of 1 μM. Group: Pharmaceutical. CAS No. 159432-28-7. Pack Sizes: 10 mg. Product ID: BAT-006218. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| A 779 TFA | A 779 TFA is a potent angiotensin (1-7) receptor antagonist. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Product ID: BAT-016355. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| A-80915 A | A-80915 A is a naphthoquinone antibiotic produced by Streptomyces aculeolatus A80915. Activity against gram-positive bacteria. Group: Pharmaceutical. CAS No. 127875-60-9. Pack Sizes: 1mg; 1g; 10g. Product ID: BBF-03167. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| A-80915 B | A-80915 B is a naphthoquinone antibiotic produced by Streptomyces aculeolatus A80915. Activity against gram-positive bacteria. Group: Pharmaceutical. CAS No. 127875-61-0. Pack Sizes: 1mg; 1g; 10g. Product ID: BBF-03168. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| A-80915 C | A-80915 C is a naphthoquinone antibiotic produced by Streptomyces aculeolatus A80915. Activity against gram-positive bacteria. Group: Pharmaceutical. CAS No. 127875-62-1. Pack Sizes: 1mg; 1g; 10g. Product ID: BBF-03169. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| A-80915 D | A-80915 D is a naphthoquinone antibiotic produced by Streptomyces aculeolatus A80915. Activity against gram-positive bacteria. Group: Pharmaceutical. CAS No. 127875-63-2. Pack Sizes: 1mg; 1g; 10g. Product ID: BBF-03170. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| A-82548A | A82548A is a macrolide antibiotic containing spiroacetal produced by Streptomyces diastatochromogenes. Group: Pharmaceutical. CAS No. 171423-45-3. Pack Sizes: 1mg; 1g; 10g. Product ID: BBF-03171. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| A-83-01 | A 83-01 is an inhibitor of TGF-β type I receptor kinase (ALK5), activin type IB receptor (ALK4), and nodal type I receptor (ALK7) (IC50s = 12, 45, and 7.5 nM, respectively). It blocks the phosphorylation of SMAD2/3 and inhibits TGF-β-induced epithelial-to-mesenchymal transition. Group: Pharmaceutical. CAS No. 909910-43-6. Pack Sizes: 50 mg. Product ID: B0084-155117. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| A83016A | A83016A is a kinamycin antibiotic produced by an unidentified actinomycete 83016. It has activity against gram-positive bacteria such as Staphylococcus, Streptococcus, Streptococcus pneumoniae and Enterococcus. The MIC is between 0.06-4.0 μg/mL, similar to other members of the Kinamycin group. Group: Pharmaceutical. CAS No. 142383-42-4. Pack Sizes: 1mg; 1g; 10g. Product ID: BBF-03172. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| A83016F | A83016F is an Aurodox antibiotic produced by an unidentified actinomycete 83016F. It has weak antibacterial activity. Group: Pharmaceutical. CAS No. 142435-72-1. Pack Sizes: 1mg; 1g; 10g. Product ID: BBF-03513. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| A83586C | A83586C is an ester peptide antibiotic produced by Streptomyces karnatakensis. It has strong anti-Gram-positive bacteria activity, and the MIC of Staphylococcus aureus and Streptococcus is 0.008-0.06 μg/mL. The IC50 for human T-cell leukemia CCRF-CEM cells is 0.0135 μg/mL. Group: Pharmaceutical. CAS No. 116364-81-9. Pack Sizes: 1mg; 1g; 10g. Product ID: BBF-03514. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| A-887826-[d8] | The labelled analogue of A 887826. A 887826 is a potent voltage-dependent NaV1.8 channel blocker (IC50 = 11 nM in recombinant human NaV1.8 channels). A 887826 is effective on reducing tactile allodynia in neuropathic rat models. Group: Pharmaceutical. CAS No. 1794753-88-0. Pack Sizes: 1mg; 1g; 10g. Product ID: BLP-003172. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| A-966492 | A-966492 is a novel and potent inhibitor of PARP1 and PARP2 with Ki of 1 nM and 1.5 nM, respectively. Group: Pharmaceutical. CAS No. 934162-61-5. Pack Sizes: 100 mg. Product ID: B1370-286311. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| A 967079 | A 967079 is a selective TRPA1 channel blocker (IC50 = 67 and 289 nM at human and rat TRPA1 receptors, respectively) with 1000-fold selectivity for TRPA1 over other TRP channels. A 967079 was shown to have analgesic effects in a rat osteoarthritic pain model. Group: Pharmaceutical. CAS No. 1170613-55-4. Pack Sizes: 100 mg. Product ID: B0084-359603. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| a,a,3,5-Tetramethyl-benzeneacetonitrile | a,a,3,5-Tetramethyl-benzeneacetonitrile (cas# 93748-07-3) is a compound useful in organic synthesis. Group: Pharmaceutical. CAS No. 93748-07-3. Pack Sizes: 1mg; 1g; 10g. Product ID: BB076776. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| AA3-DLin | AA3-Dlin is an ionizable amino lipid that has been used in combination with other lipids in the formation of lipid nanoparticles (LNPs) for the delivery of mRNA. Group: Pharmaceutical. CAS No. 2832061-33-1. Pack Sizes: 1mg; 1g; 10g. Product ID: BPG-3659. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| AA-57 | AA-57 is an acidic lipophilic antibiotic produced by Streptomyces sp. AA-57. It has anti-gram-positive bacteria, negative bacteria and mycobacterial activity. Group: Pharmaceutical. CAS No. 68026-87-9. Pack Sizes: 1mg; 1g; 10g. Product ID: BBF-03182. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| AABD-SH (4-Acetamido-7-mercapto-2,1,3-benzoxadiazole | AABD-SH (4-Acetamido-7-mercapto-2,1,3-benzoxadiazole) [for HPLC Labeling] is usefuil for developing an ultrafine atmospheric pressure plasma jet. Group: Pharmaceutical. CAS No. 254973-02-9. Pack Sizes: 1mg; 1g; 10g. Product ID: BB075657. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Aacephate-[Methoxy-d3,Thiomethoxy-d3] | Acephate-[d6] is a labelled Acephate, which is an organophosphate foliar insecticide. Group: Pharmaceutical. CAS No. 2109699-73-0. Pack Sizes: 1mg; 1g; 10g. Product ID: BLP-007159. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| a,a-Difluoro-benzeneacetyl Chloride | a,a-Difluoro-benzeneacetyl Chloride. Group: Pharmaceutical. CAS No. 312-24-3. Pack Sizes: 1mg; 1g; 10g. Product ID: BB073938. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Aaf-Arg-OH HCl | Aaf-Arg-OH HCl, a substrate of carboxypeptidase B-type enzymes, has been used to determine the activation of TAFI (thrombin activatable fibrinolysis inhibitor, carboxypeptidase U) by thrombin and thrombin-thrombomodulin. Group: Pharmaceutical. CAS No. 442158-31-8. Pack Sizes: 1mg; 1g; 10g. Product ID: BAT-015297. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| AAF-CMK trifluoroacetate salt | AAF-CMK is a serine protease inhibitor which irreversibly inhibits TPPII (tripeptidyl peptidase II), a giant protease which may substitute for some proteasome function, and reversibly inhibits Cln2 (TPPI). Group: Pharmaceutical. CAS No. 184901-82-4. Pack Sizes: 100 mg. Product ID: BAT-015706. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| AAI101 | AAI101 is a novel β-lactamase inhibitor with activity against extended-spectrum β-lactamases (ESBL), as well as, some class A and class D carbapenemases. Uses: Beta-lactamase inhibitors. Group: Pharmaceutical. CAS No. 1001404-83-6. Pack Sizes: 50 mg. Product ID: B2693-007726. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| AalDefD | AalDefD is an antimicrobial peptide produced by Aedes albopictus (Yellowfever mosquito). It has antimicrobial activity and has three intramolecular disulfide bonds. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Product ID: BAT-013192. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| A-ALLOCRYPTOPINE | A-ALLOCRYPTOPINE. Group: Pharmaceutical. CAS No. 476-33-5. Pack Sizes: 1mg; 1g; 10g. Product ID: NP0076. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| AA-PEG-AA, MW 600-20k | AA-PEG-AA has two identical activated carboxyl terminal groups. The carboxyl group reacts with the amino group to modify the molecule. Homobifunctionalized PEG derivatives have wide applications in peptides, proteins, lipids, other small molecules and surface modifications. The PEG is a highly hydrophilic molecule containing a large amount of ethoxy groups, which causes high hydrodynamic volume in aqueous solution. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Product ID: BPG-0401. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| a-Artemether-[d3] | Labelled Derivative of Artemisinin (A777500). Shows antimalarial and antifungal activity. Group: Pharmaceutical. CAS No. 93861-34-8. Pack Sizes: 1mg; 1g; 10g. Product ID: BLP-017571. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| AB-0022A | AB-0022A is an antibiotic produced by Dictyostelium purpureum K1001. It has anti-Gram-positive bacteria activity, the MIC against Staphylococcus is 0.39-3.13 μg/mL, and the MIC against Streptococcus and Enterococcus is 25-50 μg/mL. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Product ID: BBF-03183. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| AB023 A | AB023 A is a pentaene macrolide antibiotic produced by Streptomyces sp. SD581 and K9925278. It has the activity against several pathogenic fungi such as black koji and Candida albicans. The MIC of Botrytis cinerea is 5 μg/mL. Group: Pharmaceutical. CAS No. 141443-39-2. Pack Sizes: 1mg; 1g; 10g. Product ID: BBF-03184. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| AB023 B | AB023 B is a pentaene macrolide antibiotic produced by Streptomyces sp. SD581 and K9925278. It has the activity against several pathogenic fungi such as black koji and Candida albicans. Group: Pharmaceutical. CAS No. 141443-40-5. Pack Sizes: 1mg; 1g; 10g. Product ID: BBF-03185. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| AB 3217-A | AB3217-A is an anti-mite substance produced by Streptomyces platensis AB2317. Group: Pharmaceutical. CAS No. 139158-99-9. Pack Sizes: 1mg; 1g; 10g. Product ID: BBF-03190. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| AB-400 | AB-400 is a tetraene macrolide produced by Streptomyces costae. It has anti-Candida activity with an MIC of 4.6-18.0 μg/mL, which is lower than Nystatin and Amphotrecin B. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Product ID: BBF-03189. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| AB 5046 A | AB 5046 A is a substance produced by Nodulisporium AB5046 that causes plant chlorosis. It has the activity of inducing chlorosis of monocotyledonous and dicotyledonous plants. Group: Pharmaceutical. CAS No. 154037-62-4. Pack Sizes: 1mg; 1g; 10g. Product ID: BBF-03191. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| AB 5046 B | AB 5046 B is a substance produced by Nodulisporium AB5046 that causes plant chlorosis. It has the activity of inducing chlorosis of monocotyledonous and dicotyledonous plants. Group: Pharmaceutical. CAS No. 154037-63-5. Pack Sizes: 1mg; 1g; 10g. Product ID: BBF-03192. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| AB928 | AB928 is a dual antagonist of the A2aR and A2bR adenosine receptors with Kb of 1.5 and 2.0 nM, respectively. It potently blocks the immunosuppressive effects of high adenosine concentrations in the tumor microenvironment. Group: Pharmaceutical. CAS No. 2239273-34-6. Pack Sizes: 50 mg. Product ID: B2693-334167. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Abacavir 5'-4-Chloro-6-methylpyrimidine-2,5-diamine-[d4] | Abacavir 5'-4-Chloro-6-methylpyrimidine-2,5-diamine-[d4] is the labelled analogue of Abacavir 5'-4-Chloro-6-methylpyrimidine-2,5-diamine, which is a degradation product of Abacavir Sulfate, a nucleoside reverse transcriptase inhibitor (NRTI). Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Product ID: BLP-006946. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Abacavir CABS-1 Methyl Ester | Abacavir CABS-1 Methyl Ester, is an impurity of Abacavir (A105000), a carbocyclic 2'-deoxyguanosine nucleoside reverse transcriptase inhibitor and an anti-HIV drug used to treat HIV infection. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Product ID: BB075644. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Abacavir-[d4] | Abacavir-[d4] is the labelled analogue of Abacavir, which is a nucleoside reverse transcriptase inhibitor. Group: Pharmaceutical. CAS No. 1260619-56-4. Pack Sizes: 1mg; 1g; 10g. Product ID: BLP-011757. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Abacavir-[d5] | Labelled Abacavir. Abacavir sulfate is a nucleoside analog reverse transcriptase inhibitor (NRTI); guanosine analog used to treat HIV and AIDS. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Product ID: BLP-003173. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Abacavir Impurities | Abacavir Impurities refer to by-products found during the synthesis of Abacavir, an antiretroviral medication used to treat HIV infection. Monitoring and controlling these impurities is crucial for ensuring the safety, efficacy, and quality of Abacavir, thereby playing a pivotal role in HIV management. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Abaecin | Abaecin is an antimicrobial peptide produced by Apis mellifera (Honeybee). It has antibacterial activity. Group: Pharmaceutical. CAS No. 123997-18-2. Pack Sizes: 1mg; 1g; 10g. Product ID: BAT-013187. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Abaecin 1 precursor | Abaecin 1 precursor is an antimicrobial peptide produced by Solenopsis invicta (Red imported fire ant). It has antimicrobial activity. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Product ID: BAT-013184. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Abaecin isoform 1 | Abaecin isoform 1 is an antimicrobial peptide produced by Bombus terrestris (Buff-tailed bumblebee). It has antimicrobial activity. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Product ID: BAT-013185. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Abaecin isoform 2 | Abaecin isoform 2 is an antimicrobial peptide produced by Bombus terrestris (Buff-tailed bumblebee). It has antimicrobial activity. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Product ID: BAT-013186. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Abaecin-like | Abaecin-like is an antimicrobial peptide produced by Bombus impatiens (Bumblebee). It has antimicrobial activity. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Product ID: BAT-013197. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Abaloparatide | Abaloparatide is an analogue of parathyroid hormone-related protein (PTHrP) which is used for the treatment of osteoporosis. In 28 April 2017, it was approved by FDA for the treatment of postmenopausal women with osteoporosis. Studies showed that abaloparatide could decrease the risk of new vertebral and nonvertebral fractures. Uses: The treatment of osteoporosis. Group: Pharmaceutical. CAS No. 247062-33-5. Pack Sizes: 1 mg. Product ID: BAT-006119. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Abaloparatide acetate | Abaloparatide acetate, an effective and selective activator of the PTHR1 signaling pathway, is an analog of parathyroid hormone-related protein (PTHrP) used for the treatment of osteoporosis. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Product ID: BAT-016365. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Abaloparatide TFA | Abaloparatide TFA is an analog of parathyroid hormone-related protein (PTHrP) used for the treatment of osteoporosis. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Product ID: BAT-016324. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Abamectin | Avermectin B1 (Abamectin) is a widely used insecticide and anthelmintic. It is a mixture of avermectins containing more than 80% avermectin B1a and less than 20% avermectin B1b, which have very similar biological and toxicological properties. Avermectin B1 is a natural fermentation product of this bacterium. Group: Pharmaceutical. CAS No. 71751-41-2. Pack Sizes: 1mg; 1g; 10g. Product ID: BBF-05730. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Abamectin Impurities | Abamectin Impurities are critical in the biomedical field for analyzing the purity and efficacy of abamectin-based insecticides. This analysis ensures the safe and effective treatment of parasitic infections caused by nematodes and other pests, which is crucial for maintaining both human and animal health in agricultural and medical settings. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Abametapir-[d6] | Abametapir-[d6] is an isotopic labelled of Abametapir. Abametapir is the active ingredient of Xeglyze Lotion. Abametapir inhibits metalloproteinases, enzymes that are essential to physiological processes critical for egg development and the survival of nymph and adult lice. Group: Pharmaceutical. CAS No. 1803416-92-3. Pack Sizes: 1mg; 1g; 10g. Product ID: BLP-003174. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Abarelix | Abarelix is a synthetic decapeptide and antagonist of naturally occurring gonadotropin-releasing hormone (GnRH). Abarelix directly and competitively binds to and blocks the gonadotropin releasing hormone receptor in the anterior pituitary gland, thereby inhibiting the secretion and release of luteinizing hormone (LH) and follicle stimulating hormone (FSH). In males, the inhibition of LH secretion prevents the release of testosterone. As a result, this may relieve symptoms associated with prostate hypertrophy or prostate cancer, since testosterone is required to sustain prostate growth. Check for active clinical trials or closed clinical trials using this agent. Group: Pharmaceutical. CAS No. 183552-38-7. Pack Sizes: 10 mg. Product ID: BAT-006166. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Abbeymycin | Abbeymycin is an antibiotic isolated from the Streptomyces sp. AB-999F52. Abbeymycin has weak antibacterial activity against several anaerobic bacteria (such as Bacteroides fragilis, Bacteroides polymorpha, Peptococcus and Peptostreptococcus, etc.). Group: Pharmaceutical. CAS No. 108073-64-9. Pack Sizes: 1mg; 1g; 10g. Product ID: BBF-00537. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| ABCB1 | ABCB1, a CXC receptor ligand from the extracellular matrix (ECM), is produced during airway inflammation. Its activity links ECM degradation to neutrophil recruitment in airway inflammation. It may be a biomarker and therapeutic target for neutrophil inflammatory diseases. Group: Pharmaceutical. CAS No. 292171-04-1. Pack Sizes: 1mg; 1g; 10g. Product ID: BAT-015361. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Abecarnil Impurities | Abecarnil Impurities are analytical standards used in the biomedical industry to ensure the purity and efficacy of Abecarnil, a therapeutic agent for anxiety disorders. These impurities play a crucial role in quality control, enabling researchers to evaluate drug safety and efficacy in treating anxiety-related conditions. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Abemaciclib | Abemaciclib is an orally available cyclin-dependent kinase (CDK) inhibitor that targets the CDK4 (cyclin D1) and CDK6 (cyclin D3) cell cycle pathway, with potential antineoplastic activity. It is used for the treatment of advanced or metastatic breast cancers. Group: Pharmaceutical. CAS No. 1231929-97-7. Pack Sizes: 100 mg. Product ID: B0084-462724. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Abemaciclib-[13C4,15N2] | Abemaciclib-[13C4,15N2] is a labelled Abemaciclib. Abemaciclib is an orally available cyclin-dependent kinase (CDK) inhibitor that targets the CDK4 (cyclin D1) and CDK6 (cyclin D3) cell cycle pathway, with potential antineoplastic activity. It is used for the treatment of advanced or metastatic breast cancers. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Product ID: BLP-014039. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Abemaciclib-[d10] | Labelled Abemaciclib. Abemaciclib is an orally available cyclin-dependent kinase (CDK) inhibitor that targets the CDK4 (cyclin D1) and CDK6 (cyclin D3) cell cycle pathway, with potential antineoplastic activity. It is used for the treatment of advanced or metastatic breast cancers. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Product ID: BLP-003175. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Abemaciclib-[d5] | Labelled Abemaciclib. Abemaciclib is an orally available cyclin-dependent kinase (CDK) inhibitor that targets the CDK4 (cyclin D1) and CDK6 (cyclin D3) cell cycle pathway, with potential antineoplastic activity. It is used for the treatment of advanced or metastatic breast cancers. Group: Pharmaceutical. CAS No. 1809251-51-1. Pack Sizes: 1mg; 1g; 10g. Product ID: BLP-003176. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Abemaciclib-[d7] | Labelled Abemaciclib. Abemaciclib is an orally available cyclin-dependent kinase (CDK) inhibitor that targets the CDK4 (cyclin D1) and CDK6 (cyclin D3) cell cycle pathway, with potential antineoplastic activity. It is used for the treatment of advanced or metastatic breast cancers. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Product ID: BLP-003177. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Abemaciclib-[d8] | Labelled Abemaciclib. Abemaciclib is an orally available cyclin-dependent kinase (CDK) inhibitor that targets the CDK4 (cyclin D1) and CDK6 (cyclin D3) cell cycle pathway, with potential antineoplastic activity. It is used for the treatment of advanced or metastatic breast cancers. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Product ID: BLP-003178. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Abemaciclib Impurity 1-[d12] | Abemaciclib Impurity 1-[d12] is a labelled impurity of Abemaciclib. Abemaciclib is an orally available cyclin-dependent kinase (CDK) inhibitor that targets the CDK4 (cyclin D1) and CDK6 (cyclin D3) cell cycle pathway, with potential antineoplastic activity. It is used for the treatment of advanced or metastatic breast cancers. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Product ID: BLP-003179. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Abemaciclib Impurity 1-[d5] | Abemaciclib Impurity 1-[d5] is a labelled impurity of Abemaciclib. Abemaciclib is an orally available cyclin-dependent kinase (CDK) inhibitor that targets the CDK4 (cyclin D1) and CDK6 (cyclin D3) cell cycle pathway, with potential antineoplastic activity. It is used for the treatment of advanced or metastatic breast cancers. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Product ID: BLP-003180. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Abemaciclib Impurity 5-[d5] | Abemaciclib Impurity 5-[d5] is a labelled impurity of Abemaciclib. Abemaciclib is an orally available cyclin-dependent kinase (CDK) inhibitor that targets the CDK4 (cyclin D1) and CDK6 (cyclin D3) cell cycle pathway, with potential antineoplastic activity. It is used for the treatment of advanced or metastatic breast cancers. Group: Pharmaceutical. CAS No. 1809251-58-8. Pack Sizes: 1mg; 1g; 10g. Product ID: BLP-003181. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| abemaciclib mesylate | Abemaciclib mesylate is a CDK inhibitor with selectivity for CDK4 and CDK6. It was approved for the treatment of advanced or metastatic breast cancers. Uses: The treatment of advanced or metastatic breast cancers. Group: Pharmaceutical. CAS No. 1231930-82-7. Pack Sizes: 1 g. Product ID: B2693-463381. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
Would you like to list your products on UK Chemical Suppliers?
Our database is helping our users find suppliers everyday.